CLINICAL_TRIALS trial_result · 2011-09-13

Clinical Trial Update: A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension [Phase 2]

Phase 2 clinical trial update reporting dose-related efficacy and safety findings for PS433540 in hypertension; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Ligand Pharmaceuticals | Conditions: Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2011-09-13